TrialEuropean heart journal2020

Effect of alirocumab on cardiovascular outcomes after acute coronary syndromes according to age: an ODYSSEY OUTCOMES trial analysis.

Peter R Sinnaeve et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.